Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954706 · ClinicalTrials.gov registry record · NA
Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
A NA study, sponsored by Baltimore VA Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01954706 is a NA study that was terminated before completion, run by Baltimore VA Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT01954706, a NA study, was terminated before completion, sponsored by Baltimore VA Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Hormone receptor-positive tumors are the most common breast cancers in postmenopausal women, and drug therapies, which block the production or effects of estrogen, are the mainstay of treatment in these patients. Due to their effectiveness in postmenopausal women, aromatase inhibitors (AIs) are the standard of care for long-term estrogen suppression in these patients. Estrogen deficiency, however, results in multiple side effects. Some of the most common side effects in women taking AIs are joint and muscle aches, which promote physical deconditioning. Because of the long term use of AIs in postmenopausal breast cancer patients and the improvements in cancer-related outcomes that are observed with their use, identifying methods to reduce these side effects to maintain adherence to treatment is important. Exercise interventions in breast cancer patients also improve quality of life and reduce fatigue. Understanding the role of exercise in AI side effect prevention will allow us to translate these findings into therapy guidelines.
Interventions
- OTHER Usual Care
- OTHER Structured Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01954706
The ClinicalTrials.gov registry entry for NCT01954706 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baltimore VA Medical Center, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01954706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01954706 about?
NCT01954706 is a clinical study titled "Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients". Hormone receptor-positive tumors are the most common breast cancers in postmenopausal women, and drug therapies, which block the production or effects of estrogen, are the mainstay of treatment in these patients. Due to their effectiveness in postmenopausal women, aromatase inhibitors (AIs) are the ...
What is the current status of trial NCT01954706?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-11. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01954706?
The interventions under investigation include: Usual Care (OTHER), Structured Exercise (OTHER).
Who is sponsoring clinical trial NCT01954706?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.